These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 31361213

  • 1. Synergistic in vitro activity between aztreonam and amoxicillin-clavulanate against Enterobacteriaceae-producing class B and/or class D carbapenemases with or without extended-spectrum β-lactamases.
    Ract P, Compain F, Robin F, Decre D, Gallah S, Podglajen I.
    J Med Microbiol; 2019 Sep; 68(9):1292-1298. PubMed ID: 31361213
    [Abstract] [Full Text] [Related]

  • 2. Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.
    Avery LM, Nicolau DP.
    Int J Antimicrob Agents; 2018 Nov; 52(5):688-691. PubMed ID: 30044946
    [Abstract] [Full Text] [Related]

  • 3. Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
    Jesumirhewe C, Springer B, Lepuschitz S, Allerberger F, Ruppitsch W.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607027
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
    Skarp KP, Shams A, Montelin H, Lagerbäck P, Tängdén T.
    Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
    [Abstract] [Full Text] [Related]

  • 8. Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.
    Chew KL, Tay MKL, Cheng B, Lin RTP, Octavia S, Teo JWP.
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760136
    [No Abstract] [Full Text] [Related]

  • 9. An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate.
    Thomson GK, Ayaz M, Lutes K, Thomson KS.
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29046407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RA.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [Abstract] [Full Text] [Related]

  • 12. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S, Woodford N, Hope R, Adkin R, Livermore DM.
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [Abstract] [Full Text] [Related]

  • 13. Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.
    Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L.
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858212
    [Abstract] [Full Text] [Related]

  • 14. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B, Soubirou JF, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergistic activity of aztreonam (AZT) plus novel and old β-lactamase inhibitor combinations against metallo-β-lactamase-producing AZT-resistant Enterobacterales.
    Cervino I, Gonzalez D, Nastro M, Vega J, Reyes AP, Buriano G, Vay C, Famiglietti A, Rodriguez CH.
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605763
    [Abstract] [Full Text] [Related]

  • 16. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S, Vickers A, Woodford N, Livermore DM.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1688-1695. PubMed ID: 28333319
    [Abstract] [Full Text] [Related]

  • 17. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
    Watkins RR, Deresinski S.
    Expert Rev Anti Infect Ther; 2017 Oct 01; 15(10):893-895. PubMed ID: 28914107
    [No Abstract] [Full Text] [Related]

  • 18. In Vitro Comparison of Aztreonam/Amoxicillin-Clavulanate Versus Aztreonam/Ceftazidime-Avibactam on Ceftazidime-Avibactam Resistant Stenotrophomonas maltophilia.
    Crémet L, Joffraud L, Eschapasse E, Bihouée T, Tissot A, Gibaud S, Persyn E.
    Microb Drug Resist; 2022 Aug 01; 28(8):877-881. PubMed ID: 35763306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In Vitro and In Vivo Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.
    Gupta A, Malik S, Kaminski M, Landman D, Quale JM.
    Microb Drug Resist; 2022 Apr 01; 28(4):419-424. PubMed ID: 35451880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.